Kit‐San Yuen

4.0k total citations · 2 hit papers
31 papers, 2.7k citations indexed

About

Kit‐San Yuen is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Kit‐San Yuen has authored 31 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Kit‐San Yuen's work include interferon and immune responses (10 papers), Viral-associated cancers and disorders (9 papers) and Viral Infections and Vectors (5 papers). Kit‐San Yuen is often cited by papers focused on interferon and immune responses (10 papers), Viral-associated cancers and disorders (9 papers) and Viral Infections and Vectors (5 papers). Kit‐San Yuen collaborates with scholars based in Hong Kong, China and Japan. Kit‐San Yuen's co-authors include Dong‐Yan Jin, Chi‐Ping Chan, Sin‐Yee Fung, Zi‐Wei Ye, Shuofeng Yuan, Kin‐Hang Kok, Kwok‐Yung Yuen, Kam‐Leung Siu, Man Lung Yeung and Carlos Castaño-Rodríguez and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kit‐San Yuen

27 papers receiving 2.6k citations

Hit Papers

Zoonotic origins of human coronaviruses 2019 2026 2021 2023 2020 2019 200 400 600

Peers

Kit‐San Yuen
Chi‐Ping Chan Hong Kong
Aiping Wu China
Zheng Zhu China
Philip V’kovski Switzerland
Mart M. Lamers Netherlands
David J. Gregory United States
Chi‐Ping Chan Hong Kong
Kit‐San Yuen
Citations per year, relative to Kit‐San Yuen Kit‐San Yuen (= 1×) peers Chi‐Ping Chan

Countries citing papers authored by Kit‐San Yuen

Since Specialization
Citations

This map shows the geographic impact of Kit‐San Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit‐San Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit‐San Yuen more than expected).

Fields of papers citing papers by Kit‐San Yuen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit‐San Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit‐San Yuen. The network helps show where Kit‐San Yuen may publish in the future.

Co-authorship network of co-authors of Kit‐San Yuen

This figure shows the co-authorship network connecting the top 25 collaborators of Kit‐San Yuen. A scholar is included among the top collaborators of Kit‐San Yuen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit‐San Yuen. Kit‐San Yuen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ong, Chon Phin, Zi‐Wei Ye, Chi‐Ping Chan, et al.. (2024). Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling. mBio. 15(4). e0039224–e0039224.
2.
Jangra, Sonia, et al.. (2023). Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1. PLoS Pathogens. 19(2). e1011186–e1011186. 27 indexed citations
3.
Yuen, Kit‐San, et al.. (2023). Suppression of type I and type II interferon production and signalling by Epstein-Barr virus BGLF2 protein: abridged secondary publication.. PubMed. 29 Suppl 1(1). 39–41.
4.
Yuen, Kit‐San, et al.. (2021). SARS-CoV-2 and COVID-19: revisiting the most important research questions. Cell & Bioscience. 11(1). 215–215.
5.
Jangra, Sonia, et al.. (2021). Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation. Journal of Virology. 95(20). e0102721–e0102721. 24 indexed citations
6.
Wong, Lok-Yin Roy, Zi‐Wei Ye, Pak‐Yin Lui, et al.. (2020). Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε. The Journal of Immunology. 205(6). 1564–1579. 29 indexed citations
7.
Călin, George A., et al.. (2020). Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy. Clinical Epigenetics. 12(1). 150–150. 14 indexed citations
8.
Ye, Zi‐Wei, Shuofeng Yuan, Kit‐San Yuen, et al.. (2020). Zoonotic origins of human coronaviruses. International Journal of Biological Sciences. 16(10). 1686–1697. 600 indexed citations breakdown →
9.
Yuen, Kit‐San, Zi‐Wei Ye, Sin‐Yee Fung, Chi‐Ping Chan, & Dong‐Yan Jin. (2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell & Bioscience. 10(1). 40–40. 461 indexed citations
10.
Fung, Sin‐Yee, Kit‐San Yuen, Zi‐Wei Ye, Chi‐Ping Chan, & Dong‐Yan Jin. (2020). A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerging Microbes & Infections. 9(1). 558–570. 284 indexed citations
11.
Jangra, Sonia, Kit‐San Yuen, Michael G. Botelho, & Dong‐Yan Jin. (2019). Epstein–Barr Virus and Innate Immunity: Friends or Foes?. Microorganisms. 7(6). 183–183. 56 indexed citations
12.
Wang, Pei‐Hui, Zi‐Wei Ye, Kam‐Leung Siu, et al.. (2018). Inhibition of AIM 2 inflammasome activation by a novel transcript isoform of IFI 16. EMBO Reports. 19(10). 70 indexed citations
13.
Chaudhary, Vidyanath, Kit‐San Yuen, Jasper Fuk‐Woo Chan, et al.. (2017). Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein. Journal of Virology. 91(14). 87 indexed citations
14.
Yuen, Kit‐San, et al.. (2017). Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9. Virus Research. 244. 296–303. 41 indexed citations
15.
Yuen, Kit‐San, et al.. (2017). Suppression of IFN-β production by Epstein-Barr virus lytic transactivator Zta. The Journal of Immunology. 198(Supplement_1). 214.15–214.15. 2 indexed citations
16.
Lui, Pak‐Yin, Lok-Yin Roy Wong, Kam‐Leung Siu, et al.. (2016). Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerging Microbes & Infections. 5(1). 1–9. 104 indexed citations
17.
Yuen, Chun‐Kit, Ching-Ping Chan, Sin‐Yee Fung, et al.. (2016). Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation. Journal of Virology. 90(8). 3902–3912. 31 indexed citations
18.
Yuen, Kit‐San, Chi‐Ping Chan, Kin‐Hang Kok, & Dong‐Yan Jin. (2016). Mutagenesis and Genome Engineering of Epstein–Barr Virus in Cultured Human Cells by CRISPR/Cas9. Methods in molecular biology. 1498. 23–31. 22 indexed citations
19.
Gao, Weiwei, Chi‐Ping Chan, Yun Cheng, et al.. (2014). Requirement of CRTC1 coactivator for hepatitis B virus transcription. Nucleic Acids Research. 42(20). 12455–12468. 24 indexed citations
20.
Chan, Shun‐Wan, et al.. (2012). Effects and Mechanism of Turmeric Vasorelaxation of the Thoracic Aorta in Hypercholesterolemic Rats. Journal of Medicinal Food. 15(2). 190–199. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026